RBC Capital raised the firm’s price target on RB Global (RBA) to $116 from $107 and keeps an Outperform rating on the shares. The company ...
In a report released yesterday, Tom Narayan from RBC Capital maintained a Buy rating on Visteon (VC – Research Report), with a price target of ...
Performance Trust Capital Partners is pleased to announce the addition of Craig Buchner to its Institutional Sales group, further expanding its expertise in Collateralized Loan Obligations (CLOs) and ...
While RBC continues to see value in Centrica, with the stock trading at around 4.5 times its estimated 2025 EBITDA, the firm ...
Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...
European miners are scheduled to report fourth-quarter and full-year results over the next four weeks. Gold prices are trading near record highs as investors turn to safe haven assets as economic and ...
RBC Capital Markets adjusted its price target for Fidelity National Information Services (NYSE:FIS), a leading provider of ...
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
will speak at the RBC Capital Markets Global Financial Institutions Conference in New York at 2:00 p.m. ET on Tuesday, March 4, 2025. The discussion may include forward-looking statements and ...
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
The National Association of Insurance Commissioners (NAIC) has formed the Risk-Based Capital Model Governance Task Force to reassess and ...
State of Alaska Department of Revenue lifted its position in RBC Bearings Incorporated (NYSE:RBC – Free Report) by 5.8% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results